MET Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MetLife Inc (MET) is not an ideal buy for a beginner, long-term investor at this moment. Despite a strong revenue increase in the latest quarter, the company's declining net income and EPS, bearish technical indicators, and lack of positive trading signals suggest limited upside potential. Additionally, hedge fund selling and a high put-call ratio in options data indicate bearish sentiment. It is better to wait for clearer signs of recovery or improved sentiment before investing.
The technical indicators for MET are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 35.432, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 74.466, with key support at 70.753 and resistance at 78.179.
Revenue increased by 26.69% YoY in Q4 2025, reflecting strong top-line growth. Analysts maintain an overall positive stance with multiple 'Overweight' and 'Buy' ratings.
Hedge funds are aggressively selling, with a 119,940.49% increase in selling activity last quarter. Options data shows bearish sentiment with a high put-call ratio. The stock has no recent AI Stock Picker or SwingMax signals.
In Q4 2025, revenue increased to $23.67 billion (up 26.69% YoY), but net income dropped to $778 million (down 37.21% YoY), and EPS fell to 1.17 (down 34.27% YoY). Gross margin remained flat.
Analysts have lowered price targets recently, with the current range between $90 and $100. While most analysts maintain 'Overweight' or 'Buy' ratings, there are concerns about valuation, earnings pressure, and exposure to commercial mortgage loans.
